Aspire Biopharma Holdings, Inc. Common Stock logo

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Q4 2024 Annual Earnings

ASBP·Reported April 7, 2025·Before market open

Diluted EPS came in at $-0.27.

Diluted EPS
$-0.27
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001641172-25-002917

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Aspire Biopharma Holdings, Inc. Common Stock's Q4 2024 earnings report.

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) reported Q4 2024 earnings on April 7, 2025 before market open.

Aspire Biopharma Holdings, Inc. Common Stock reported diluted EPS of $-0.27 for Q4 2024.

You can read the 10-K periodic report (0001641172-25-002917) directly on SEC EDGAR. The filing index links above go to sec.gov.